2020 Q1 Form 10-K Financial Statement

#000139047820000007 Filed on March 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 2018 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $2.200M $9.923M $2.640M
YoY Change -12.0% -22.31% -55.93%
% of Gross Profit
Research & Development $1.864M $7.285M $3.650M
YoY Change 0.27% -16.9% 414.08%
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $4.064M $17.21M $6.290M
YoY Change -6.77% -20.11% -26.69%
Operating Profit -$4.064M -$20.04M
YoY Change
Interest Expense $20.00K $120.0K $30.00K
YoY Change 100.0% -144.44% -100.5%
% of Operating Profit
Other Income/Expense, Net -$100.0K -$19.37M $950.0K
YoY Change -47.37% -33.31% 427.78%
Pretax Income -$4.140M -$19.37M -$14.86M
YoY Change -8.81% -33.31% 87.63%
Income Tax -$81.00K -$1.540M
% Of Pretax Income
Net Earnings -$4.143M -$19.29M -$13.32M
YoY Change -8.68% -30.28% -645.9%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$649.9K -$7.535M -$30.27M
COMMON SHARES
Basic Shares Outstanding 6.718M shares 22.03M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.700M $7.280M $5.300M
YoY Change 157.69% 36.33% 130.43%
Cash & Equivalents $6.700M $7.280M $5.337M
Short-Term Investments
Other Short-Term Assets $2.100M $650.0K $500.0K
YoY Change 162.5% 30.0% -95.33%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $8.790M $8.240M $5.838M
YoY Change 157.32% 41.1% -55.39%
LONG-TERM ASSETS
Property, Plant & Equipment $100.0K $220.0K
YoY Change -80.0%
Goodwill $1.914M $1.900M
YoY Change 0.0% -0.73%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $500.0K $540.0K $700.0K
YoY Change -16.67% -18.18% -22.22%
Total Long-Term Assets $8.236M $8.370M $11.08M
YoY Change -28.45% -24.46% -45.8%
TOTAL ASSETS
Total Short-Term Assets $8.790M $8.240M $5.838M
Total Long-Term Assets $8.236M $8.370M $11.08M
Total Assets $17.03M $16.61M $16.92M
YoY Change 14.06% -1.83% -49.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.624M $3.900M $3.755M
YoY Change -43.42% 3.72% -67.88%
Accrued Expenses $888.0K $1.390M $2.219M
YoY Change 10.04% -32.85% -30.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $3.635M $5.290M $5.974M
YoY Change -37.37% -11.39% -75.68%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $5.100M $4.960M $5.300M
YoY Change -12.07% -7.12% 103.85%
Total Long-Term Liabilities $5.100M $4.960M $0.00
YoY Change -12.07% -7.12% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.635M $5.290M $5.974M
Total Long-Term Liabilities $5.100M $4.960M $0.00
Total Liabilities $8.964M $10.52M $11.67M
YoY Change -25.16% -9.85% -62.9%
SHAREHOLDERS EQUITY
Retained Earnings -$105.3M -$81.86M
YoY Change 21.89% 51.07%
Common Stock $113.4M $87.10M
YoY Change 26.87% 54.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.062M $6.090M $5.245M
YoY Change
Total Liabilities & Shareholders Equity $17.03M $16.61M $16.92M
YoY Change 14.06% -1.83% -49.55%

Cashflow Statement

Concept 2020 Q1 2019 2018 Q4
OPERATING ACTIVITIES
Net Income -$4.143M -$19.29M -$13.32M
YoY Change -8.68% -30.28% -645.9%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$6.831M -$17.64M -$4.550M
YoY Change 36.87% -42.01% 161.49%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change -100.0%
Common Stock Issuance & Retirement, Net $5.988M $15.97M
YoY Change -25.94%
Debt Paid & Issued, Net $0.00
YoY Change -100.0%
Cash From Financing Activities $6.300M $19.57M -80.00K
YoY Change 182.51% -15.37% -33.33%
NET CHANGE
Cash From Operating Activities -$6.831M -$17.64M -4.550M
Cash From Investing Activities 0.000
Cash From Financing Activities $6.300M $19.57M -80.00K
Net Change In Cash -$531.0K $1.926M -4.630M
YoY Change -80.77% -126.39% -144.95%
FREE CASH FLOW
Cash From Operating Activities -$6.831M -$17.64M -$4.550M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001390478
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6717900 shares
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q2 dei Entity Public Float
EntityPublicFloat
11217186 USD
CY2019 dei Entity Registrant Name
EntityRegistrantName
SELLAS Life Sciences Group, Inc.
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018 gale Change In Fair Value Of Common Stock Warrants Issued In Connection With Various Equity Financings
ChangeInFairValueOfCommonStockWarrantsIssuedInConnectionWithVariousEquityFinancings
5302000 USD
CY2019 gale Change In Fair Value Of Common Stock Warrants Issued In Connection With Various Equity Financings
ChangeInFairValueOfCommonStockWarrantsIssuedInConnectionWithVariousEquityFinancings
1136000 USD
CY2018 gale Change In Fair Value Of Contingent Purchase Consideration
ChangeInFairValueOfContingentPurchaseConsideration
-3032000 USD
CY2019 gale Change In Fair Value Of Contingent Purchase Consideration
ChangeInFairValueOfContingentPurchaseConsideration
-586000 USD
CY2018 gale Change In Fair Value Of Contingent Purchase Price Consideration
ChangeInFairValueOfContingentPurchasePriceConsideration
-3032000 USD
CY2019 gale Change In Fair Value Of Contingent Purchase Price Consideration
ChangeInFairValueOfContingentPurchasePriceConsideration
-586000 USD
CY2019 gale Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-1136000 USD
CY2018 gale Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
81000 shares
CY2019 gale Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
3590000 shares
CY2018 gale Classof Warrantor Right Canceled Or Expired
ClassofWarrantorRightCanceledOrExpired
11000 shares
CY2019 gale Classof Warrantor Right Canceled Or Expired
ClassofWarrantorRightCanceledOrExpired
0 shares
CY2019 gale Conversionwith Series A Convertible Preferred Stock
ConversionwithSeriesAConvertiblePreferredStock
0 USD
CY2019Q4 gale Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
47000 USD
CY2018 gale Conversionwith Series A Convertible Preferred Stock
ConversionwithSeriesAConvertiblePreferredStock
4436000 USD
CY2018Q3 gale Classof Warrantor Right Exercise Priceof Warrantsor Rights Prefunded
ClassofWarrantorRightExercisePriceofWarrantsorRightsPrefunded
0.005
CY2019Q2 gale Classof Warrantor Right Exercise Priceof Warrantsor Rights Prefunded
ClassofWarrantorRightExercisePriceofWarrantsorRightsPrefunded
0.005
CY2018 gale Classof Warrantor Right Granted
ClassofWarrantorRightGranted
427000 shares
CY2019 gale Classof Warrantor Right Granted
ClassofWarrantorRightGranted
3536000 shares
CY2017Q4 gale Classof Warrantor Right Term
ClassofWarrantorRightTerm
P5Y
CY2018Q3 gale Classof Warrantor Right Term
ClassofWarrantorRightTerm
P5Y
CY2019Q4 gale Closing Price Of Common Stock
ClosingPriceOfCommonStock
4.30
CY2019Q4 gale Common Stock Capital Shares Reserved For Future Issuance Of Employee Stock Purchase Plan
CommonStockCapitalSharesReservedForFutureIssuanceOfEmployeeStockPurchasePlan
5000 shares
CY2018Q4 gale Contingent Purchase Price Consideration Net Of Current Portion
ContingentPurchasePriceConsiderationNetOfCurrentPortion
4326000 USD
CY2019Q4 gale Contingent Purchase Price Consideration Net Of Current Portion
ContingentPurchasePriceConsiderationNetOfCurrentPortion
4912000 USD
CY2018Q4 gale Contract Research Payable
ContractResearchPayable
858000 USD
CY2019Q4 gale Contract Research Payable
ContractResearchPayable
371000 USD
CY2018 gale Convertible Preferred Stock Dividends
ConvertiblePreferredStockDividends
487000 USD
CY2018 gale Deferred Offering Costs Included In Accounts Payable And Accrued Expenses
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
0 USD
CY2019 gale Deferred Offering Costs Included In Accounts Payable And Accrued Expenses
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
135000 USD
CY2018Q4 gale Deferred Tax Assets Licensing Deduction Deferral
DeferredTaxAssetsLicensingDeductionDeferral
5961000 USD
CY2019Q4 gale Deferred Tax Assets Licensing Deduction Deferral
DeferredTaxAssetsLicensingDeductionDeferral
5139000 USD
CY2019Q4 gale Deferred Tax Liability Right Of Use Asset
DeferredTaxLiabilityRightOfUseAsset
47000 USD
CY2018 gale Dividend Arising From Warrant Modifications
DividendArisingFromWarrantModifications
0 USD
CY2019 gale Dividend Arising From Warrant Modifications
DividendArisingFromWarrantModifications
8416000 USD
CY2018 gale Dividend Modification Of Warrants Net
DividendModificationOfWarrantsNet
-491000 USD
CY2019 gale Dividend Modification Of Warrants Net
DividendModificationOfWarrantsNet
-243000 USD
CY2018 gale Dividend On Conversion Of Series A Convertible Preferred Stock
DividendOnConversionOfSeriesAConvertiblePreferredStock
4436000 USD
CY2018 gale Dividend On Conversion Of Series A Convertible Preferred Stock Most Favored Nation Net
DividendOnConversionOfSeriesAConvertiblePreferredStockMostFavoredNationNet
8654000 USD
CY2018 gale Dividend On Conversion Of Series A Convertible Preferred Stock Most Favored Nation Net
DividendOnConversionOfSeriesAConvertiblePreferredStockMostFavoredNationNet
8700000 USD
CY2019 gale Dividend On Conversion Of Series A Convertible Preferred Stock Most Favored Nation Net
DividendOnConversionOfSeriesAConvertiblePreferredStockMostFavoredNationNet
0 USD
CY2018 gale Effective Income Tax Rate Reconciliation Contingent Consideration Percent
EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent
-0.038
CY2019 gale Effective Income Tax Rate Reconciliation Contingent Consideration Percent
EffectiveIncomeTaxRateReconciliationContingentConsiderationPercent
0.045
CY2018 gale Effective Income Tax Rate Reconciliation Fair Value Change Warrants Percent
EffectiveIncomeTaxRateReconciliationFairValueChangeWarrantsPercent
0.005
CY2019 gale Effective Income Tax Rate Reconciliation Fair Value Change Warrants Percent
EffectiveIncomeTaxRateReconciliationFairValueChangeWarrantsPercent
-0.065
CY2018 gale Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.018
CY2019 gale Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.011
CY2019 gale Employee Service Share Based Compensation Unrecognized Compensation Costs
EmployeeServiceShareBasedCompensationUnrecognizedCompensationCosts
1000000 USD
CY2019 gale Employee Service Share Based Compensation Unrecognized Compensation Costs Weighted Average Period Of Recognition
EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsWeightedAveragePeriodOfRecognition
P2Y4M9D
CY2019 gale Fair Value Of Warrants Canceled
FairValueOfWarrantsCanceled
68000 USD
CY2019 gale Fair Value Of Warrants Exercise Price Adjustment
FairValueOfWarrantsExercisePriceAdjustment
243000 USD
CY2018 gale Fair Value Of Warrants Issued In Connection With Common Stock Recorded As Cost Of Equity
FairValueOfWarrantsIssuedInConnectionWithCommonStockRecordedAsCostOfEquity
5350000 USD
CY2019 gale Fair Value Of Warrants Issued In Connection With Common Stock Recorded As Cost Of Equity
FairValueOfWarrantsIssuedInConnectionWithCommonStockRecordedAsCostOfEquity
0 USD
CY2018Q4 gale Fair Value Of Warrants Liabilities
FairValueOfWarrantsLiabilities
1013000 USD
CY2019Q4 gale Fair Value Of Warrants Liabilities
FairValueOfWarrantsLiabilities
52000 USD
CY2018Q4 gale Fair Value Of Warrants Potentially Settleable In Cash
FairValueOfWarrantsPotentiallySettleableInCash
1013000 USD
CY2019Q4 gale Fair Value Of Warrants Potentially Settleable In Cash
FairValueOfWarrantsPotentiallySettleableInCash
52000 USD
CY2019 gale Fair Valueof Warrants Granted
FairValueofWarrantsGranted
0 USD
CY2018Q4 gale Impact On Tax Provision From Unrecognized Tax Benefits
ImpactOnTaxProvisionFromUnrecognizedTaxBenefits
55000 USD
CY2018Q4 gale In Process Research Development
InProcessResearchDevelopment
8500000 USD
CY2018Q4 gale Rebates And Returns Of Former Commercial Products
RebatesAndReturnsOfFormerCommercialProducts
138000 USD
CY2019 gale Sharebased Compensation Arrangementby Sharebased Payment Award Options Vested And Exercisable Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedAndExercisableWeightedAverageRemainingContractualTerm
P8Y3M4D
CY2019Q4 gale Rebates And Returns Of Former Commercial Products
RebatesAndReturnsOfFormerCommercialProducts
0 USD
CY2019Q4 gale In Process Research Development
InProcessResearchDevelopment
5700000 USD
CY2018 gale Increase Decrease In Fair Value Of Warrant Liability
IncreaseDecreaseInFairValueOfWarrantLiability
491000 USD
CY2019 gale Increase Decrease In Fair Value Of Warrant Liability
IncreaseDecreaseInFairValueOfWarrantLiability
200000 USD
CY2019 gale Increase Decrease In Fair Value Of Warrant Liability
IncreaseDecreaseInFairValueOfWarrantLiability
243000 USD
CY2018 gale Liability Classified Warrants Antidilution Protection
LiabilityClassifiedWarrantsAntidilutionProtection
491000 USD
CY2019 gale Liability Classified Warrants Antidilution Protection
LiabilityClassifiedWarrantsAntidilutionProtection
243000 USD
CY2018 gale Longterm Debt Issued In Connection With Warrant Exchanges
LongtermDebtIssuedInConnectionWithWarrantExchanges
966000 USD
CY2019 gale Longterm Debt Issued In Connection With Warrant Exchanges
LongtermDebtIssuedInConnectionWithWarrantExchanges
0 USD
CY2018 gale Loss On Settlement Of Liability Classified Warrants
LossOnSettlementOfLiabilityClassifiedWarrants
727000 USD
CY2019 gale Loss On Settlement Of Liability Classified Warrants
LossOnSettlementOfLiabilityClassifiedWarrants
0 USD
CY2018 gale Loss On Settlement Of Warrants Liability
LossOnSettlementOfWarrantsLiability
727000 USD
CY2019 gale Loss On Settlement Of Warrants Liability
LossOnSettlementOfWarrantsLiability
0 USD
CY2019 gale Maximum Indefinitelived Deferred Tax Liability As Percentage Of Net Operating Loss
MaximumIndefinitelivedDeferredTaxLiabilityAsPercentageOfNetOperatingLoss
0.80
CY2018 gale Net Proceeds From Exercise Of Common Stock Warrants
NetProceedsFromExerciseOfCommonStockWarrants
0 USD
CY2019 gale Net Proceeds From Exercise Of Common Stock Warrants
NetProceedsFromExerciseOfCommonStockWarrants
3598000 USD
CY2019 gale Operating Lease Remaining Lease Term
OperatingLeaseRemainingLeaseTerm
P1Y
CY2019 gale Operating Loss And Tax Credit Carryforwards Limitations On Use Minimum Change In Ownership Percentage
OperatingLossAndTaxCreditCarryforwardsLimitationsOnUseMinimumChangeInOwnershipPercentage
0.5
CY2019Q4 gale Options Reserved For Future Issuance Under Companies Incentive Plan
OptionsReservedForFutureIssuanceUnderCompaniesIncentivePlan
203000 shares
CY2019 gale Percentage Increase In Number Of Shares Available For Future Issuance Under Stock Based Awards
PercentageIncreaseInNumberOfSharesAvailableForFutureIssuanceUnderStockBasedAwards
0.01
CY2018Q4 gale Prepaid Professional Services
PrepaidProfessionalServices
56000 USD
CY2019Q4 gale Prepaid Professional Services
PrepaidProfessionalServices
49000 USD
CY2018Q4 gale Prepaid Research And Development
PrepaidResearchAndDevelopment
48000 USD
CY2019Q4 gale Prepaid Research And Development
PrepaidResearchAndDevelopment
224000 USD
CY2019 gale Proceedsfrom Issuance Of Costs
ProceedsfromIssuanceOfCosts
19600000 USD
CY2018 gale Reclassification Of Warrant Liabilities Upon Exchange For Shares Of Common Stock
ReclassificationOfWarrantLiabilitiesUponExchangeForSharesOfCommonStock
285000 USD
CY2019 gale Reclassification Of Warrant Liabilities Upon Exchange For Shares Of Common Stock
ReclassificationOfWarrantLiabilitiesUponExchangeForSharesOfCommonStock
68000 USD
CY2019Q4 gale Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableNumber
1906 shares
CY2019 gale Share Based Compensation Arrangement By Share Based Payment Award Percentage Earning Of Participants
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageEarningOfParticipants
0.15
CY2019Q4 gale Sharebased Compensation Arrangementby Sharebased Payment Award Options Vested And Exercisable Weighted Average Exercise Price
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice
261.03
CY2014Q3 gale Shares Issued Under License Agreement
SharesIssuedUnderLicenseAgreement
263 shares
CY2017Q2 gale Shares Issued Under License Agreement
SharesIssuedUnderLicenseAgreement
175 shares
CY2018 gale Stock Issued During Period Value Common Stockand Warrants
StockIssuedDuringPeriodValueCommonStockandWarrants
21564000 USD
CY2019 gale Stock Issued During Period Value Common Stockand Warrants
StockIssuedDuringPeriodValueCommonStockandWarrants
16144000 USD
CY2019 gale Stock Issued During Period Value Pre Funded Warrant
StockIssuedDuringPeriodValuePreFundedWarrant
8000 USD
CY2018 gale Stock Subscription Receivable
StockSubscriptionReceivable
0 USD
CY2019 gale Stock Subscription Receivable
StockSubscriptionReceivable
308000 USD
CY2018Q4 gale Stock Subscription Receivable Current
StockSubscriptionReceivableCurrent
0 USD
CY2019Q4 gale Stock Subscription Receivable Current
StockSubscriptionReceivableCurrent
300000 USD
CY2019Q4 gale Stock Subscription Receivable Current
StockSubscriptionReceivableCurrent
308000 USD
CY2018 gale Warrant Exchange Agreements Amount
WarrantExchangeAgreementsAmount
285000 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
5300000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3755000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3902000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2219000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1171000 USD
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
540000 USD
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
194000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
87099000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
107235000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-4436000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
395000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
573000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
-5039000 USD
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
395000 USD
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
573000 USD
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
364000 shares
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
324000 shares
CY2018Q4 us-gaap Assets
Assets
16915000 USD
CY2019Q4 us-gaap Assets
Assets
16609000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
5838000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
8242000 USD
CY2018Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
8500000 USD
CY2019Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
5700000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5337000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7277000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7300000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12750000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5451000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7377000 USD
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7299000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1926000 USD
CY2017Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
371.00
CY2018Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
105
CY2018Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2017Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
6323 shares
CY2018Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
230400 shares
CY2019Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2000000 shares
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
21000 shares
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
356000 shares
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
302000 shares
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
532000 shares
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
440529 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5080100 shares
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1317000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-95000 USD
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-570000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1785000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1267000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
357000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
262000 USD
CY2018 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1316000 USD
CY2019 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-95000 USD
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
440529 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5080100 shares
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
5000 USD
CY2018 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
3721000 USD
CY2019 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
CY2018Q3 us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
7871186 USD
CY2018Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
74963 shares
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
31089000 USD
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
20041000 USD
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-106000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-61000 USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
14000 USD
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
45000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
14000 USD
CY2018 us-gaap Decrease In Restricted Cash
DecreaseInRestrictedCash
1800000 USD
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-747000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-117000 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
22000 USD
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
12838000 USD
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
13992000 USD
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1428000 USD
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1005000 USD
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1428000 USD
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1005000 USD
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4464000 USD
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6720000 USD
CY2018Q4 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
56000 USD
CY2019Q4 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
27000 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
134000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
0 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2223000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2059000 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11410000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12987000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
357000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
262000 USD
CY2018Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
1785000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts
1220000 USD
CY2018 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0 USD
CY2019 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
38000 USD
CY2018Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
663000 USD
CY2019Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
536000 USD
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-157.72
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-10.92
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.047
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.235
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.099
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.139
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2018 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.086
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.118
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.008
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.010
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.011
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
-0.005
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
675000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
606000 USD
CY2018 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5300000 USD
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1136000 USD
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
766000 USD
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2018Q4 us-gaap Goodwill
Goodwill
1914000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
1900000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1914000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1900000 USD
CY2018 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
9550000 USD
CY2019 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
2833000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-17179000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-8477000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29048000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19372000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-11869000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-10895000 USD
CY2018 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-27670000 USD
CY2019 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-19292000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1378000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-27670000 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30422000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17643000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
11670000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
10516000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16915000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16609000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5974000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5290000 USD
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23123000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19569000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-81000 USD
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7936000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
12000 USD
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2282000 USD
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1048000 USD
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-212000 USD
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
76000 USD
CY2018 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-266000 USD
CY2019 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
118000 USD
CY2018 us-gaap Interest Paid Net
InterestPaidNet
321000 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2018 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1250000 USD
CY2019 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
224000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-19292000 USD
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-41251000 USD
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27951000 USD
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-29048000 USD
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19373000 USD
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
400000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
217000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
217000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
217000 USD
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.13
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
0 USD
CY2018 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
9100000 USD
CY2019 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
2833000 USD
CY2018 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2041000 USD
CY2019 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
668000 USD
CY2018Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
129000 USD
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
84000 USD
CY2018 us-gaap Paid In Kind Interest
PaidInKindInterest
134000 USD
CY2019 us-gaap Paid In Kind Interest
PaidInKindInterest
0 USD
CY2018 us-gaap Payments Of Dividends
PaymentsOfDividends
487000 USD
CY2019 us-gaap Payments Of Dividends
PaymentsOfDividends
0 USD
CY2018 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
4436000 USD
CY2019 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
387000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
557000 USD
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
154000 USD
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
200000 USD
CY2018Q4 us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
500000 USD
CY2018 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
186000 USD
CY2019 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
118000 USD
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
21564000 USD
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15971000 USD
CY2018 us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
9647000 USD
CY2019 us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
0 USD
CY2018 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7601000 USD
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8767000 USD
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7285000 USD
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
114000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
100000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
100000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81855000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101147000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101100000 USD
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
549000 USD
CY2018Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
21600000 USD
CY2019Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
13400000 USD
CY2019 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
300000 USD
CY2019 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
75000 shares
CY2018Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
105
CY2019Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
25.00
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12772000 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9923000 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
395000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
573000 USD
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8083
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9657
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0273
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0249
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2000 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4930 shares
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
9650 shares
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
18800 shares
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
186.50
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
54.00
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7650 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
22000 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
21520 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.00
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
261.09
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
112.81
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 USD
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
264.77
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
175.86
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
261.96
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
69.00
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M12D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M24D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y2M19D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y11M23D
CY2019 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P10Y
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9647000 USD
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3658000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
5245000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
6093000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2070000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5245000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6093000 USD
CY2019Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.02
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
72000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
55000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
17000 USD
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
55000 USD
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1600000 USD
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
261542 shares
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2558755 shares
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;font-style:italic;">Concentration of Credit Risk</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash on deposit with multiple financial institutions, the balances of which frequently exceed federally insured limits.</font></div></div>
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;">The preparation of these consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Helvetica,sans-serif;font-size:10pt;">On an ongoing basis, the Company evaluates its estimates using historical experience and other factors, including the current economic environment. Significant items subject to such estimates are assumptions used for purposes of determining stock-based compensation, the fair value of the warrants, fair value of intangible assets acquired, carrying value of goodwill, fair value of contingent purchase price consideration, fair value of deferred tax liability assumed and accounting for research and development activities. Management believes its estimates to be reasonable under the circumstances. Actual results could differ significantly from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0001390478-20-000007-index-headers.html Edgar Link pending
0001390478-20-000007-index.html Edgar Link pending
0001390478-20-000007.txt Edgar Link pending
0001390478-20-000007-xbrl.zip Edgar Link pending
basketstudyschema2.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gale-20191231.xml Edgar Link completed
gale-20191231.xsd Edgar Link pending
gale-20191231_cal.xml Edgar Link unprocessable
gale-20191231_def.xml Edgar Link unprocessable
gale-20191231_lab.xml Edgar Link unprocessable
gale-20191231_pre.xml Edgar Link unprocessable
gpsmoaa01.jpg Edgar Link pending
mpmschema.jpg Edgar Link pending
phase3schemav2.jpg Edgar Link pending
pipelinev3.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sellas-logoa11.jpg Edgar Link pending
Show.js Edgar Link pending
sls-20191231x10k.htm Edgar Link pending
sls20191231ex1048.htm Edgar Link pending
sls20191231ex1049.htm Edgar Link pending
sls20191231ex231.htm Edgar Link pending
sls20191231ex311.htm Edgar Link pending
sls20191231ex312.htm Edgar Link pending
sls20191231ex321.htm Edgar Link pending
sls20191231ex441.htm Edgar Link pending
wt1cancersa02.jpg Edgar Link pending